According to Tarsus Pharmaceuticals's latest financial reports the company's current earnings are A$0.12 Billion. In 2023 the company made an earning of -A$0.22 Billion a decrease over its 2022 earnings that were of -A$97.49 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -A$0.2 Billion | -11.59% |
2023 | -A$0.22 Billion | 121.28% |
2022 | -A$97.49 Million | 380.03% |
2021 | -A$20.31 Million | -53.74% |
2020 | -A$43.91 Million |